ReviewBiomedicines2024

Combination of Anti-Angiogenics and Immunotherapies in Renal Cell Carcinoma Show Their Limits: Targeting Fibrosis to Break through the Glass Ceiling?

Manon Teisseire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.